PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. Electronic address: figuero44@gmail.com.\', \'Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.\', \'Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Servicio de Oncología Médica, Complejo Universitario de Ávila, Ávila, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2173-5743(20)30131-310.1016/j.reumae.2020.06.008
?:hasPublicationType
?:journal
  • Reumatologia clinica
is ?:pmid of
?:pmid
?:pmid
  • 34823820
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.539
?:rankingScore_hIndex
  • 17
is ?:relation_isRelatedTo_publication of
?:title
  • Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34823820>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34823820>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all